Announced Mon, 3 Aug · 14:02 IST
Q1 FY27 PAT up 29% standalone, 235% consolidated on strong revenue growth
Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults View source PDFExplain this filing
BHAGCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.7%1-day move
₹289.00
prior close
₹310.90
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.1-0.3-0.5-2.1-0.7-2.2-4.8+0.3-1.7-2.9————
Up moveDown movePending
AI summary
Standalone revenue from operations rose to 17,367.32 lakhs in Q1 FY27 versus 12,377.78 lakhs YoY, about 40% growth. Standalone PAT grew to 1,068.10 lakhs versus 828.73 lakhs, up about 29%. Consolidated revenue jumped to 19,501.89 lakhs and PAT to 1,332.92 lakhs versus 397.91 lakhs YoY, helped by subsidiary Bheema Fine Chemicals. PBT nearly doubled on standalone basis. EPS at 0.82 standalone and 1.03 consolidated. Statutory auditors gave an unmodified opinion.
Likely market impact
Strong YoY growth in revenue and profit, especially at consolidated level, signals improving operating performance and subsidiary ramp-up.